| Nov'19 | Nov'18 | Nov'17 | Nov'16 | Nov'15 | Nov'14 | |
|---|---|---|---|---|---|---|
Operating activities: | ||||||
Net income | ||||||
499,400 | 539,200 | 417,000 | 152,100 | 240,200 | 194,500 | |
Reconciliation of net income to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
573,100 | 541,200 | 492,500 | 335,700 | 235,500 | 202,100 | |
Stock-based compensation expense | ||||||
223,800 | 241,700 | 261,900 | 206,200 | 135,400 | 167,400 | |
Gain on sale of assets | ||||||
115,300 | 0 | 0 | 41,500 | 0 | 0 | |
Impairment of assets | ||||||
- | - | - | - | 4,600 | 0 | |
Excess tax benefit from stock-based compensation | ||||||
- | - | - | 5,600 | 5,500 | 13,300 | |
Net periodic pension and postretirement expense | ||||||
2,800 | -5,600 | 6,900 | 10,000 | 4,500 | 6,700 | |
Undistributed earnings of affiliates, net | ||||||
-400 | 800 | -5,200 | -2,900 | 0 | 0 | |
Pension and postretirement contributions | ||||||
2,000 | 2,600 | 5,700 | 5,700 | 5,900 | 13,500 | |
Deferred income taxes | ||||||
49,600 | 211,700 | 100,100 | -6,700 | 34,900 | 10,300 | |
Change in assets and liabilities: | ||||||
Accounts receivable, net | ||||||
67,900 | 11,800 | 27,500 | 8,500 | -56,100 | -36,400 | |
Other current assets | ||||||
79,900 | 2,200 | 34,600 | -12,300 | 15,600 | 8,800 | |
Accounts payable | ||||||
30,900 | 32,500 | -20,000 | -12,500 | -4,100 | -11,400 | |
Accrued expenses | ||||||
39,700 | 82,500 | -42,800 | 35,600 | -100 | 36,200 | |
Income tax | ||||||
88,700 | 23,500 | -14,700 | -44,700 | 32,100 | 6,300 | |
Deferred revenue | ||||||
38,800 | 26,600 | 4,700 | -14,600 | -34,200 | 29,700 | |
Other liabilities | ||||||
68,400 | 37,000 | 18,700 | 9,900 | 4,500 | 6,100 | |
Net cash provided by operating activities | ||||||
1,251,300 | 1,289,500 | 961,500 | 638,300 | 612,600 | 628,100 | |
Investing activities: | ||||||
Capital expenditures on property and equipment | ||||||
278,100 | 222,700 | 260,200 | 147,600 | 122,900 | 114,500 | |
Intangible assets acquired | ||||||
- | - | - | - | - | 700 | |
Acquisitions of businesses, net of cash acquired | ||||||
136,500 | 1,876,200 | 401,100 | 1,014,400 | 369,900 | 210,400 | |
Proceeds from sale of assets | ||||||
163,500 | 0 | 0 | 190,900 | 0 | 0 | |
Change in other assets | ||||||
18,300 | 6,200 | -500 | 4,500 | 3,800 | 4,600 | |
Settlements of forward contracts | ||||||
2,100 | 7,000 | -14,500 | 7,200 | -600 | -6,200 | |
Net cash provided by (used in) investing activities | ||||||
-271,500 | -2,112,100 | -646,300 | -982,800 | -496,000 | -324,000 | |
Financing activities: | ||||||
Proceeds from borrowings | ||||||
2,631,700 | 4,617,000 | 3,194,500 | 4,018,000 | 550,000 | 2,485,000 | |
Repayment of borrowings | ||||||
3,188,900 | 3,122,600 | 2,381,200 | 3,364,800 | 261,200 | 2,817,200 | |
Payment of debt issuance costs | ||||||
13,200 | 30,800 | 14,400 | 22,800 | 0 | 19,000 | |
Payments for purchase of noncontrolling interests | ||||||
0 | 10,100 | 57,000 | 0 | 0 | - | |
Proceeds from noncontrolling interests | ||||||
12,500 | 0 | 7,500 | 0 | 0 | - | |
Contingent consideration payments | ||||||
2,200 | 43,000 | 2,600 | 0 | 0 | - | |
Proceeds from the exercise of employee stock options | ||||||
177,700 | 230,000 | 331,600 | 147,300 | 0 | 0 | |
Payments related to tax withholding for stock-based compensation | ||||||
75,600 | 95,000 | 89,900 | 35,800 | 48,500 | - | |
Repurchases of common shares | ||||||
500,000 | 672,500 | 1,317,800 | 570,000 | 200,400 | 59,900 | |
Excess tax benefit from stock-based compensation | ||||||
- | - | - | 5,600 | 5,500 | 13,300 | |
Net cash used in financing activities | ||||||
-958,000 | 873,000 | -329,300 | 177,500 | 45,400 | -397,800 | |
Foreign exchange impact on cash balance | ||||||
-30,300 | -64,200 | 9,000 | 12,800 | -22,100 | -11,500 | |
Net increase in cash and cash equivalents | ||||||
-8,500 | -13,800 | -5,100 | -154,200 | 139,900 | -105,200 | |